Studies on 1-arylpiperazine derivatives with affinity for rat 5-HT7 and 5-HT1A receptors. 2004

Marcello Leopoldo, and Francesco Berardi, and Nicola A Colabufo, and Marialessandra Contino, and Enza Lacivita, and Roberto Perrone, and Vincenzo Tortorella
Dipartimento Farmaco-Chimico, Università degli Studi di Bari, via Orabona, 4, 70125 Bari, Italy. leopoldo@farmchim.uniba.it

Several 1-aryl-4-(2-arylethyl)piperazine derivatives were synthesized and tested in-vitro for their binding affinity for 5-HT(7) and 5-HT(1A) receptors. These compounds displayed 5-HT(7 )receptor affinity ranging between K(i) = 474 nM and K(i) = 8.2 nM, besides high affinity for the 5-HT(1A) receptor. Intrinsic activity of the most potent compounds was assessed. 4-[2-(3-Methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine (16) and 1-(1,2-benzisoxazol-3-yl)-4-[2-(3-methoxyphenyl)ethyl]piperazine (20) (K(i) = 24.5 and 8.2 nM, respectively) behaved as partial agonist and full agonist, respectively, when tested for 5-HT(7) receptor-mediated relaxation of substance P-induced guinea-pig ileum contraction.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008566 Membranes Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures. Membrane Tissue,Membrane,Membrane Tissues,Tissue, Membrane,Tissues, Membrane
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums

Related Publications

Marcello Leopoldo, and Francesco Berardi, and Nicola A Colabufo, and Marialessandra Contino, and Enza Lacivita, and Roberto Perrone, and Vincenzo Tortorella
January 2005, Journal of chemical information and modeling,
Marcello Leopoldo, and Francesco Berardi, and Nicola A Colabufo, and Marialessandra Contino, and Enza Lacivita, and Roberto Perrone, and Vincenzo Tortorella
October 1988, Journal of medicinal chemistry,
Marcello Leopoldo, and Francesco Berardi, and Nicola A Colabufo, and Marialessandra Contino, and Enza Lacivita, and Roberto Perrone, and Vincenzo Tortorella
February 2011, Bioorganic & medicinal chemistry,
Marcello Leopoldo, and Francesco Berardi, and Nicola A Colabufo, and Marialessandra Contino, and Enza Lacivita, and Roberto Perrone, and Vincenzo Tortorella
January 2003, Bioorganic & medicinal chemistry letters,
Marcello Leopoldo, and Francesco Berardi, and Nicola A Colabufo, and Marialessandra Contino, and Enza Lacivita, and Roberto Perrone, and Vincenzo Tortorella
January 2012, Pharmacological reports : PR,
Marcello Leopoldo, and Francesco Berardi, and Nicola A Colabufo, and Marialessandra Contino, and Enza Lacivita, and Roberto Perrone, and Vincenzo Tortorella
December 2004, Bioorganic & medicinal chemistry letters,
Marcello Leopoldo, and Francesco Berardi, and Nicola A Colabufo, and Marialessandra Contino, and Enza Lacivita, and Roberto Perrone, and Vincenzo Tortorella
August 2009, Behavioural brain research,
Marcello Leopoldo, and Francesco Berardi, and Nicola A Colabufo, and Marialessandra Contino, and Enza Lacivita, and Roberto Perrone, and Vincenzo Tortorella
May 2000, Bioorganic & medicinal chemistry letters,
Marcello Leopoldo, and Francesco Berardi, and Nicola A Colabufo, and Marialessandra Contino, and Enza Lacivita, and Roberto Perrone, and Vincenzo Tortorella
May 2012, Neuroreport,
Marcello Leopoldo, and Francesco Berardi, and Nicola A Colabufo, and Marialessandra Contino, and Enza Lacivita, and Roberto Perrone, and Vincenzo Tortorella
July 2014, CNS neuroscience & therapeutics,
Copied contents to your clipboard!